Docosahexaenoic acid inhibits development of hypoxic pulmonary hypertension: in vitro and in vivo studies.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  International Journal of Cardiology

• Publication date

  2013-10-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2013.07.073PMID 23907044
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Omega-3 and omega-6 fatty acid intakes and endometrial cancer risk in a population-based case–control study

  2013cited by this paper
• Phrenic long-term facilitation after acute intermittent hypoxia requires spinal ERK activation but not TrkB synthesis.

  2012cited by this paper
• Long chain N-3 polyunsaturated fatty acids in the prevention of allergic and cardiovascular disease.

  2012cited by this paper
• N-3 long-chain polyunsaturated fatty acids inhibit smooth muscle cell migration by modulating urokinase plasminogen activator receptor through MEK/ERK-dependent and -independent mechanisms.

  2012cited by this paper
• Docosahexaenoic acid-induced unfolded protein response, cell cycle arrest, and apoptosis in vascular smooth muscle cells are triggered by Ca2+-dependent induction of oxidative stress

  2012cited by this paper
• DHA derivatives of fish oil as dietary supplements: a nutrition-based drug discovery approach for therapies to prevent metabolic cardiotoxicity

  2012cited by this paper
• ERK1/2 MAP kinases: structure, function, and regulation.

  2012cited by this paper
• cGMP-dependent protein kinase Iα transfection inhibits hypoxia-induced migration, phenotype modulation and annexins A1 expression in human pulmonary artery smooth muscle cells.

  2012cited by this paper
• Docosahexaenoic Acid Exerts Anti-Inflammatory Action on Human Eosinophils through Peroxisome Proliferator-Activated Receptor-Independent Mechanisms

  2012cited by this paper
• Docosahexaenoic fatty acid (DHA) in the regulation of colon cell growth and cell death: a review.

  2012cited by this paper
• New mechanisms of pulmonary arterial hypertension: role of Ca²⁺ signaling.

  2012cited by this paper
• Digoxin inhibits development of hypoxic pulmonary hypertension in mice

  2012cited by this paper
• (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?

  2012cited by this paper
• Eicosapentaenoic acid and docosahexaenoic acid inhibit macrophage-induced gastric cancer cell migration by attenuating the expression of matrix metalloproteinase 10.

  2012cited by this paper
• Long chain omega-3 fatty acids and cardiovascular disease: a systematic review

  2012cited by this paper
• [Experimental models and new approaches to the treatment of pulmonary hypertension].

  2012cited by this paper
• Statins inhibit pulmonary artery smooth muscle cell proliferation by upregulation of HO-1 and p21WAF1

  2012cited by this paper
• Lack of Bcr and Abr Promotes Hypoxia-Induced Pulmonary Hypertension in Mice

  2012cited by this paper
• A mechanism underlying the effects of polyunsaturated fatty acids on breast cancer

  2012cited by this paper
• 15-Lipoxygenase Metabolites of Docosahexaenoic Acid Inhibit Prostate Cancer Cell Proliferation and Survival

  2012cited by this paper
• The role of ERK1/2 in 15-HETE-inhibited apoptosis in pulmonary arterial smooth muscle cells

  2011cited by this paper
• Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation.

  2011cited by this paper
• The role of the right ventricle in pulmonary arterial hypertension

  2011cited by this paper
• Pulmonary microcirculation in interstitial lung disease.

  2011cited by this paper
• PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer

  2011cited by this paper
• Moderate consumption of fatty fish reduces diastolic blood pressure in overweight and obese European young adults during energy restriction.

  2010cited by this paper
• Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition.

  2010cited by this paper
• Tissue factor pathway inhibitor overexpression inhibits hypoxia-induced pulmonary hypertension.

  2010cited by this paper
• Acute hypoxia promote the phosphorylation of tau via ERK pathway.

  2010cited by this paper
• Comparative effects of DHA and EPA on cell function.

  2009cited by this paper
• Cellular and molecular basis of pulmonary arterial hypertension.

  2009cited by this paper
• The role of NADPH oxidase in chronic intermittent hypoxia-induced pulmonary hypertension in mice.

  2009cited by this paper
• Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism.

  2009cited by this paper
• Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression

  2008cited by this paper
• COPD: A Pediatric Disease

  2008cited by this paper
• Induction of vascular remodeling in the lung by chronic house dust mite exposure.

  2008cited by this paper
• Pathobiology of pulmonary hypertension.

  2007cited by this paper
• Low-dose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women.

  2007cited by this paper
• How valid are animal models to evaluate treatments for pulmonary hypertension?

  2006cited by this paper
• Antiarrhythmic and electrophysiological effects of long-chain omega-3 polyunsaturated fatty acids.

  2005cited by this paper
• Antiarrhythmic and electrophysiological effects of long-chain ω-3 polyunsaturated fatty acids

  2005cited by this paper
• Eicosapentaenoic acid and docosahexaenoic acid inhibit vascular smooth muscle cell proliferation by inhibiting phosphorylation of Cdk2-cyclinE complex.

  1999cited by this paper

• Role of Anti-Inflammatory and Antioxidant Properties of Natural Products in Curing Cardiovascular Diseases

  2025cites this paper
• Unlocking the gut-lung axis: Feixin decoction as a novel modulator in hypoxic pulmonary hypertension.

  2025cites this paper
• Decreased plasma docosahexaenoic acid concentration in chronic obstructive pulmonary disease patients with pulmonary Hypertension: Findings from human lipidomics and transcriptomics analysis.

  2024cites this paper
• Omega‐3 polyunsaturated fatty acids and pulmonary arterial hypertension: Insights and perspectives

  2024cites this paper
• Therapeutic Potential of Select Dietary Compounds in the Management of Hypertension and its Cardiovascular Complications

  2022cites this paper
• Autophagy in chronic lung disease.

  2020cites this paper
• Docosahexaenoic acid inhibits Ca2+ influx and downregulates CaSR by upregulating microRNA‐16 in pulmonary artery smooth muscle cells

  2020cites this paper
• Effect of Omega-3 Polyunsaturated Fatty Acids in Modulation of Vascular Tone under Physiological and Pathological Conditions.

  2020cites this paper
• Astragaloside IV attenuates hypoxia-induced pulmonary vascular remodeling via the Notch signaling pathway

  2020cites this paper
• The preventive and therapeutic effects of AAV1‐KLF4‐shRNA in cigarette smoke‐induced pulmonary hypertension

  2020cites this paper
• Somatic growth and the risks of bronchopulmonary dysplasia and pulmonary hypertension: connecting epidemiology and physiology 1.

  2019cites this paper
• Docosahexaenoic acid inhibits monocrotaline-induced pulmonary hypertension via attenuating endoplasmic reticulum stress and inflammation.

  2017influential citation
• Reoxygenation Reverses Hypoxic Pulmonary Arterial Remodeling by Inducing Smooth Muscle Cell Apoptosis via Reactive Oxygen Species–Mediated Mitochondrial Dysfunction

  2017cites this paper
• Docosahexaenoic acid causes rapid pulmonary arterial relaxation via KCa channel-mediated hyperpolarisation in pulmonary hypertension

  2016cites this paper
• Optimized EPA/DHA 6/1 formulation prevents Angiotensin-II induced hypertension and endothelial dysfunction in rats

  2016cites this paper
• Pharmacological approaches in either intermittent or permanent hypoxia: A tale of two exposures

  2015cites this paper
• TRPC6 is required for hypoxia-induced basal intracellular calcium concentration elevation, and for the proliferation and migration of rat distal pulmonary venous smooth muscle cells

  2015cites this paper
• NSFC spurs significant basic research progress of respiratory medicine in China

  2015cites this paper
• Pharmacological approaches in either intermittent or permanent hypoxia: A tale of two exposures.

  2015cites this paper
• Viewing cancer pathophysiology as a lead in understanding cardiac and vascular disease mechanisms

  2014cites this paper